Belgian MedTech start-up regenerates cartilage
Breakthrough innovation in regenerative medicine.
Allegro is the latest revelation in the Flemish biotech landscape. The start-up is working on a revolutionary technology for regenerative medicine. Their first product is a nanotechnology scaffold for cartilage regeneration.
Founder Jorg Schelfhout: "Allegro came about after years of research in medical biomaterials and the search for the ultimate regenerative technology."
"What we are developing is truly revolutionary, because we work a-cellular and are 100% biocompatible. This means that with just 1 quick intervention we can regrow the cells and restore the cartilage to its original state. Without adverse effects or expensive cell therapies."
Cartilage lesions are a very common medical condition. They are often caused by acute trauma (such as in athletes), or occur as a result of degenerative diseases. Today’s treatments feature removing ruptured cartilage through surgery, sutures, or certain collagen products. However, there is not yet an adequate treatment. Untreated cartilage lesions can lead to, among other things, osteoarthrosis and is therefore an important condition from a social point of view.